|
|
|
|
|
|
|
|
|
|
|
24.03.25 - 17:57
|
IBA – Share buyback (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, March 24th, 2025 - Ion Beam Applications SA (IBA) announces today the launch of a share buyback program, effective as of March 25th, 2025, in application of article 7:215 of the Belgian Companies and Associations Code....
|
|
|
20.03.25 - 10:01
|
Ion Beam Applications Aktie: Gute Zahlen und ordentlicher Ausblick (Aktiencheck)
|
|
|
Kulmbach (www.aktiencheck.de) - Ion Beam Applications-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von Ion Beam Applications SA (IBA) (ISIN: BE0003766806, WKN: 914998, Ticker-Symbol: IOB, Euronext Brüssel-Symbol: IBAB, NASDAQ OTC-Symbol: IBOCF) unter die Lupe. [mehr]...
|
|
|
|
|
04.03.25 - 11:21
|
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, March 04, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a term sheet with Apollo Hospitals Enterprise Limited (AHEL) for the supply of one Proteus®ONE1 compact proton therapy solution plus a second one in option. Apollo will therefore expand access to proton therapy in India. The term sheet was signed in the presence of Her Royal Highness Princess Astrid of Belgium....
|
|
|
18.02.25 - 16:48
|
Notice of Capital Markets Day - Save the Date (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, 18 February, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will host a Capital Markets Day (CMD) for investors and analysts on Monday 7 April 2025 at 2pm CET / 1pm GMT / 8am ET....
|
|
|
|
|
|
|
07.02.25 - 07:03
|
Framatome and IBA to partner to develop an Astatine-211 Cyclotron Network in Europe and the USA (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today announced they have signed a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (211At), an alpha-emitting radioisotope across Europe and the United States....
|
|
|
06.02.25 - 07:03
|
IBA signs Proteus®ONE system contract with AIG in Hyderabad, India (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, February 06, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a binding agreement with the Asian Institute of Gastroenterology (AIG) for the supply of a Proteus®ONE1 compact proton therapy system to be located at the new Oncology Centre within AIG Hospitals' Gachibowli campus in Hyderabad, India. The first payment has been received....
|
|
|
17.01.25 - 07:03
|
IBA announces Chief Financial Officer transition (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, January 17, 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces that Soumya Chandramouli will be stepping down from her role as Chief Financial Officer (“CFO”), effective 31 January 2025. Henri de Romrée, Deputy CEO, will oversee the financial direction at Group level until a new CFO has been appointed. Thomas Pevenage, Finance Director, will continue to lead the Group's Investor Relations function until further notice....
|
|
|
06.12.24 - 08:06
|
US ban on China affects equipment maker AIBT (Digitimes)
|
|
|
Taiwanese equipment firm Advanced Ion Beam Technology (AIBT) is expected to be negatively impacted by the US's stringent restrictions on China, with revenue from the Chinese market expected to significantly decline in 2025, according to industry sources....
|
|
|
05.12.24 - 17:48
|
New generation steps up to continue IBA′s entrepreneurial ownership (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, 5 December 2024 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, announces today an initiative aimed at perpetuating the entrepreneurial anchoring of its shareholder base. A new generation of executives will acquire a significant indirect stake in IBA. It is part of a broader strategy to ensure IBA's growth, value creation and sustainability. Company's success originates from a unique combination between entrepreneurial driving force and reference shareholding....
|
|
|
|
|
22.11.24 - 13:09
|
Ion Beam Applications: Radiopharma-Hot-Stock überzeugt – jetzt einsteigen? (Der Aktionaer)
|
|
|
Der belgische Strahlenspezialist hat in dieser Handelswoche mit dem Business-Update für das dritte Quartal überzeugen können. Die Aktie konnte daraufhin aus dem zuletzt ausgebildeten Konsolidierungstrend nach oben ausbrechen. Unterfüttert wird die gute operative Entwicklung von Ion Beam Applications durch eine Hochstufung von Analystenseite....
|
|
|
21.11.24 - 07:03
|
IBA Business Update – Third Quarter 2024 (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the third quarter ending 30 September 2024....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
